CymitQuimica logo

CAS 943319-70-8: Ponatinib

Formula:C29H27F3N6O
InChI:InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)
InChI key:InChIKey=PHXJVRSECIGDHY-UHFFFAOYSA-N
SMILES:C(#CC1=CC(C(NC2=CC(C(F)(F)F)=C(CN3CCN(C)CC3)C=C2)=O)=CC=C1C)C=4N5C(=NC4)C=CC=N5
Synonyms:
  • 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide
  • Ap 24534
  • Ap24534
  • Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-
  • Iclusig
  • Ponatinib
  • AP24534(Ponatinib)
Sort by

Found 8 products.
  • Ponatinib

    CAS:
    Ponatinib
    Purity:≥98%
    Molecular weight:532.56g/mol

    Ref: 54-BUP14504

    1g
    390.00€
    10mg
    80.00€
    50mg
    98.00€
    100mg
    153.00€
    200mg
    203.00€
  • Ponatinib

    Controlled Product
    CAS:
    Applications Ponatinib is a tyrosine kinase inhibitors (TKI) and used to treat chronic myeloid leukemia (CML) (1,2,3). Ponatinib is also used in combination with other drugs, such as forskolin, to combat TKI resistance in patient with CML (3), targeted drug in small-cell lung cancer. Potent FAK inhibitor. FGFR/VEGFR/Bcr-Abl inhibitor It is a COVID19-related research product. References (1) Poch, M. M., et al.: Expert Rev Hematol. 9, 923 (2016) (2) Shamroe, C. L. and Comeau, J. M. Ann Pharmacother. 47, 1540 (2013)(3) Oaxaca, D. M., et al.: Tumour Biol. 37, 12643 (2016)
    Formula:C29H27F3N6O
    Color and Shape:Off-White
    Molecular weight:532.56

    Ref: TR-P688250

    1mg
    96.00€
    10mg
    178.00€
    25mg
    313.00€
  • Ponatinib

    CAS:
    BCR-ABL1 tyrosine kinase inhibitor
    Formula:C29H27F3N6O
    Purity:Min. 95%
    Color and Shape:Powder
    Molecular weight:532.56 g/mol

    Ref: 3D-FP27104

    50mg
    191.00€
    100mg
    341.00€
    250mg
    505.00€
  • Ponatinib

    CAS:
    Formula:C29H27F3N6O
    Purity:≥ 98.0%
    Color and Shape:White or off-white powder or crystals
    Molecular weight:532.56

    Ref: 7W-GP1345

    10mg
    74.00€
  • Ponatinib, Free Base

    CAS:
    Ponatinib, Free Base
    Formula:C29H27F3N6O
    Purity:98%
    Color and Shape: off-white crystalline solid
    Molecular weight:532.56g/mol

    Ref: 54-BIM1122

    10mg
    37.00€
    100mg
    137.00€
    250mg
    228.00€
  • Ponatinib Glucuronide

    Controlled Product
    CAS:
    Formula:C35H35F3N6O7
    Color and Shape:Neat
    Molecular weight:709.692

    Ref: TR-P688255

    50mg
    9,054.00€
  • Ponatinib

    CAS:
    Formula:C29H27F3N6O
    Color and Shape:Pale Yellow Solid
    Molecular weight:532.57

    Ref: 4Z-P-123001

    5mg
    To inquire
    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • Ponatinib

    CAS:
    Ponatinib (AP24534) is an orally available, multitargeted kinase inhibitor (IC50s: 0.37/1.1/1.5/2.2/5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively
    Formula:C29H27F3N6O
    Purity:98% - 99.60%
    Color and Shape:Solid
    Molecular weight:532.56

    Ref: TM-T2372

    10mg
    55.00€
    50mg
    70.00€
    100mg
    99.00€
    200mg
    138.00€
    1mL*10mM (DMSO)
    55.00€